InnovAge
INNV
#6349
Rank
NZ$1.40 B
Marketcap
NZ$10.34
Share price
-0.08%
Change (1 day)
38.44%
Change (1 year)

Earnings for InnovAge (INNV)

Earnings in 2025 (TTM): -NZ$36.61 Million

According to InnovAge's latest financial reports the company's current earnings are NZ$0.88 Billion. In 2024 the company made an earning of -NZ$45.04 Million, an increase over its 2023 earnings that were of -NZ$59.71 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for InnovAge from 2020 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$36.61 Million-18.71%
2024 -NZ$45.04 Million-24.58%
2023 -NZ$59.71 Million-31.82%
2022 -NZ$87.59 Million-681.94%
2021 NZ$15.04 M-388.91%
2020 -NZ$5.21 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
AcelRx Pharmaceuticals
ACRX
-NZ$17.74 Million-50.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Horizon Therapeutics
HZNP
NZ$0.88 B-2,563.68%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Cocrystal Pharma
COCP
-NZ$16.85 Million-53.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$39.81 B-111,088.27%๐Ÿ‡บ๐Ÿ‡ธ USA